It is well known that NF-κB plays an important role in promoting growth, survival, and chemoresistance of myeloma cells in BM through the regulation of IL-6 and insulin-like growth factor 1 (IGF-1) expression [61, 62]. The gene discussed is IGF1; the disease is plasma cell myeloma.